4 NASDAQ Penny Stocks Trading Lower on May 1

nasdaq penny stocks

Many stocks are trading lower on May 1, and that includes a handful of NASDAQ penny stocks.

Here are four.

4 NASDAQ Penny Stocks Trading Lower: Second Sight Medical Products, Inc. (NASDAQ:EYES)

Second Sight Medical Products, Inc. is an American company that develops, manufactures, and markets implantable visual prosthetics, all of which are designed to deliver an artificial vision to blind individuals.

On May 1, Yahoo Finance reports that EYES stock is down 14.29% at $1.14, as of 2:21 p.m. EDT.

On March 19, the California-based company released its Q4 and full-year 2019 financial results. Chief Operating Officer Pat Ryan highlighted in the report that its development work on the Argus 2s had finished. Ryan also noted that Second Sight Medical Products received FDA conditional approval, in addition to CE Mark Certification, for these new wearables.

Furthermore, gross profit for Q4 came in at $0.4 million. For perspective, gross profit for Q4 of 2018 was $0.2 million.

The next announcement came on April 30, when Second Sight disclosed the pricing of a public offering of common stock. The company said it plans to use the net proceeds from this offering for working capital and general corporate purposes.

4 NASDAQ Penny Stocks Trading Lower: ViewRay, Inc. (NASDAQ:VRAY)

ViewRay, Inc. is an Ohio-based company that designs and markets radiation therapy systems, including MRIdian.

On May 1, Yahoo Finance reports that VRAY stock is down 8.89% at $1.895, as of 2:34 p.m. EDT, making it the second on our list of NASDAQ penny stocks trading lower on Friday.

nasdaq penny stocks

At the end of April, ViewRay, Inc. reported its financial results for Q1 2020. Highlights include that total revenue came in at $14.3 million, while the company received four new orders for its MRIdian systems, which came to a total of $22.6 million. Additionally, the total backlog was $230.8 million, and cash and cash equivalents were $190.2 million.

“As we manage in this challenging environment, we are focused on what we can control. Value creation lies in driving our clinical, innovation and commercial pipeline while enhancing efforts to conserve capital,” said CEO Scott Drake.

>> 5 Popular Penny Stocks with Solid Moves Today

4 NASDAQ Penny Stocks Trading Lower: Predictive Oncology Inc. (NASDAQ:POAI)

Predictive Oncology Inc. is a biotechnology company that applies data and artificial intelligence to personalized drug and medicine discovery. It serves customers worldwide.

On May 1, Yahoo Finance reports that POAI stock is down 1.35% at $1.46.

While Predictive Oncology Inc. is among the NASDAQ penny stocks trading lower on Friday, InvestorsObserver does report that POAI stock has increased around 16% over the past week. It also has a Bullish rating from its Sentiment Indicator.

4 NASDAQ Penny Stocks Trading Lower: NN, Inc. (NASDAQ:NNBR)

NN, Inc. is an American global diversified industrial manufacturer of high-precision metal, in addition to plastic components and assemblies.

On May 1, Yahoo Finance reports that NNBR stock is down 14.06% at $2.96, as of 2:04 p.m. EDT.

nasdaq penny stocks

On April 16, NN, Inc. announced that it had adopted a limited duration rights plan. A few weeks earlier, the company withdrew its full-year 2020 financial guidance.


Maybe things will turn around for these NASDAQ penny stocks next week. It’s a volatile time on the market, so there are no guarantees. What is clear, however, is that they are trading lower on the first of the month.

>> Read More Penny Stock News

Featured image: PixaBay

Please See Disclaimer

If You Liked This Article Click To Share

Risks and Disclosure:

Information provided in this correspondence is intended solely for informational purposes and is obtained from sources believed to be reliable. While all information is believed to be reliable, it is not guaranteed by us to be accurate. Individuals should assume that all information contained on this website is not trustworthy unless verified by their own independent research. Also, because events and circumstances frequently do not occur as expected, there will likely be differences between any predictions made or suggested and the actual results.

All statements and opinions expressed are the opinions of the author and not of Microsmallcap.com or its officers. The author is wholly responsible for the validity of all statements. Microsmallcap.com was not involved in any aspect of the article preparation. The author was not paid by Market Jar Media Inc for this article. The author did not pay Microsmallcap.com to publish or syndicate this article.

This article does not constitute as investment advice. Each reader is encouraged to consult with his or her individual financial advisor; any and all actions taken by a reader as a result of the information presented here is his or her own responsibility. By opening this page, each reader accepts and agrees to Microsmallcap.com's terms of use and full legal disclaimer. This article is in no way a solicitation for investment. Microsmallcap.com does not render general or specific investment advice. Any information on Microsmallcap.com should not be considered a recommendation to buy or sell any security. Microsmallcap.com does not endorse or recommend the business, products, services or securities of any company mentioned on Microsmallcap.com.

Futures, stocks and options trading involves substantial risk of loss and is not suitable for every investor. The valuation of futures, stocks, and options may fluctuate, and, as a result, clients may lose more than their original investment and possibly their entire investment. Any content on this website should not be relied upon as advice or construed as providing recommendations of any kind. It is your responsibility to confirm and decide which trades to make. Always consult a licensed investment professional before making any investment decision. Be extremely careful, investing in securities carries a high degree of risk; you may likely lose some or all of the investment.

Please see our full disclaimer here for additional details before making any investment decisions.